Physician
Deluise, Anthony
Deluise, Anthony was paid $11K by Medicaid between Jan 2018 and Jun 2022, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 81% of everything it billed.
33Billing provider infoDELUISE, ANTHONY
PROVIDENCE, RI 02908
PROVIDENCE, RI 02908
33aNPI1588605992assigned 06/09/2006
33bProvider typeOrthopaedic Surgery Physician
28Total paid$11K
24GClaims342
24DCodes billed7
24AFirst – last monthJan 2018 – Jun 2022
Compared with peers
Next to other Orthopaedic Surgery Physician providers in Rhode Island
Rank by total paid#33 of 44
Median peer was paid$33K
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 102 | $3K | |
| 2019 | 52 | $498.18 | |
| 2020 | 56 | $2K | |
| 2021 | 81 | $4K | |
| 2022 | 51 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 81% | 265 | 224 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.8% | 15 | 14 | $996.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.6% | 13 | 13 | $753.00 |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.1% | 12 | 12 | $351.19 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | 12 | $37.60 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12 | 12 | $12.60 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 13 | 12 | $12.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.